Literature DB >> 6919479

Controversies in the treatment of exocrine pancreatic insufficiency.

E P DiMagno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6919479     DOI： 10.1007/bf01296724

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  16 in total

1.  Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts.

Authors:  D Y Graham
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

2.  Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.

Authors:  E P DiMagno; J R Malagelada; V L Go; C G Moertel
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

3.  Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency.

Authors:  P T Regan; J R Malagelada; E P DiMagno; S L Glanzman; V L Go
Journal:  N Engl J Med       Date:  1977-10-20       Impact factor: 91.245

4.  Disturbances in fat digestion induced by acidic jejunal pH due to gastric hypersecretion in man.

Authors:  V L Go; J R Poley; A F Hofmann; W H Summerskill
Journal:  Gastroenterology       Date:  1970-05       Impact factor: 22.682

5.  Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency.

Authors:  E P DiMagno; V L Go; W H Summerskill
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

6.  Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.

Authors:  R Gow; R Bradbear; P Francis; R Shepherd
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

7.  An enteric-coated pancreatic enzyme preparation that works.

Authors:  D Y Graham
Journal:  Dig Dis Sci       Date:  1979-12       Impact factor: 3.199

8.  Medical treatment of pancreatic insufficiency.

Authors:  E P DiMagno
Journal:  Mayo Clin Proc       Date:  1979-07       Impact factor: 7.616

9.  The effect of cimetidine on maldigestion in cystic fibrosis.

Authors:  K L Cox; J N Isenberg; A B Osher; R R Dooley
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

10.  Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.

Authors:  P R Durie; L Bell; W Linton; M L Corey; G G Forstner
Journal:  Gut       Date:  1980-09       Impact factor: 23.059
View more
  8 in total

Review 1.  Uses and abuses of enzyme therapy in cystic fibrosis.

Authors:  P Durie; D Kalnins; L Ellis
Journal:  J R Soc Med       Date:  1998       Impact factor: 5.344

2.  Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations.

Authors:  A M Whitehead
Journal:  Pharm Weekbl Sci       Date:  1988-02-19

Review 3.  Laboratory measurement of nutrition in cystic fibrosis.

Authors:  J Kelleher
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

Review 4.  Colonic strictures in cystic fibrosis.

Authors:  J A Dodge; C Macpherson
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

5.  Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy.

Authors:  M J Bruno; E A Rauws; F J Hoek; G N Tytgat
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

6.  Studies on the quality of pancreatic preparations: enzyme content, prospective bioavailability, bile acid pattern, and contamination with purines.

Authors:  K H Niessen; J König; M Molitor; B Neef
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

7.  Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs.

Authors:  S M Griffin; D Alderson; J R Farndon
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

8.  Improvement of fecal fat excretion after addition of omeprazole to pancrease in cystic fibrosis is related to residual exocrine function of the pancreas.

Authors:  H G Heijerman; C B Lamers; W Bakker; J H Dijkman
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.